The level of intestinal inflammation and fibrosis in resection specimens after preoperative anti-tumour necrosis factor-α treatment in patients with Crohn’s disease: a comparative pilot study

J Torle, P Dabir, U Korsgaard, J J Christiansen, N Qvist, A El-Hussuna

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review


Strictures are a common complication in Crohn’s disease (CD), which are found in more than 50\% of the patients. They are characterised by excessive deposition of extracellular proteins in the tissue as a result of the chronic inflammatory process. The effect of anti- TNF-α therapy on the development of fibrosis is not yet fully understood. The aim of the study was to investigate whether the degree of intestinal inflammation and fibrosis correlates with pre-operative anti-TNF-α therapy in patients with Crohn’s disease undergoing bowel resection.This is an unblinded, prospective, multicentre cohort pilot study. All adult patients with Crohn’s disease, who underwent elective, laparoscopic or open intestinal resection were included. Pre-operative blood investigations included measurement of TNF- α concentration and specific drug antibodies in addition to the concentration of selected inflammatory cytokines. Three pathologists examined the specimens independently and assessed the degree of inflammation and fibrosis.Histopathological specimens from 10 patients with CD who underwent ileocecal or ileocolic resections were retrieved. Four of those patients were on anti-TNF-α treatment pre-operatively. The last dose of anti-TNF-α agents was administered within 1–9 weeks prior to bowel resection. Patients on anti-TNF-α treatment had higher fibrosis score than the controls (p = 0.01). Anti-TNF-α treatment was not associated with an increase in either CD68 or CD163-positive macrophages. There was no significant relationship between time from last anti-TNF-α dose to surgery, and fibrosis score. No significant association between the concentration of major inflammatory cytokines including TNF-α and fibrosis score or degree of inflammation was found.Patients on anti-TNF-α treatment had higher fibrosis score than the controls.
TidsskriftJournal of Crohn's and Colitis
Udgave nummerSuppl. 1
Sider (fra-til)S357-S358
Antal sider2
StatusUdgivet - jan. 2020
Begivenhed15th Congress of Ecco - Wien, Østrig
Varighed: 12 feb. 202015 feb. 2020
Konferencens nummer: 15


Konference15th Congress of Ecco

Bibliografisk note

Abstract no. P383